OHSU discovery sheds light into how stem cells become brain cellsDecember 15, 2005Continued research could result in new therapies for those who suffer brain injury, Parkinson's disease and other conditions related to lost or damaged brain cells Researchers at the Oregon National Primate Research Center at Oregon Health & Science University (OHSU) have discovered one key gene that appears to control how stem cells become various kinds of brain cells. The finding has significant implications for the study of Parkinson's disease, brain and spinal cord injury, and other conditions or diseases that might be combated by replacing lost or damaged brain cells. The research is published in the current online edition of the medical journal Developmental Biology. "In the early stages of brain development prior to birth, brain stem cells, also known as neural stem cells, will differentiate into neurons," explained Larry Sherman, Ph.D., an associate scientist in the Division of Neuroscience at the Oregon National Primate Research Center and an adjunct associate professor of cell and developmental biology in the OHSU School of Medicine. "In later stages, these same stem cells suddenly start becoming glial cells, which perform a number of functions that include supporting the neurons. We wanted to find out what factors cause this switch in differentiation. We also wanted to determine if the process can be controlled and used as a possible therapy. What amazed us is that it turns out a single gene may be responsible for this incredibly important task."
The key gene that the scientists studied is called brahma-related gene-1 (Brg-1) that is found in both mice and humans. This protein had been previously studied extensively in human cancers, but not in the nervous system. To determine the precise role of Brg-1, Sherman, in collaboration with Dr. Steven Matsumoto from the Integrative Biosciences Department at the OHSU School of Dentistry, bred mice lacking the gene in the nervous system. This resulted in the development of embryos with smaller brains containing neurons but virtually no glial cells. When they isolated neural stem cells, placed them into cell culture and then removed Brg1, the cells in the culture turned into neurons but failed to differentiate into glia. "This research shows us that in mice, Brg-1 is a critical signal that prevents stem cells from turning into neurons at the wrong time. However, since we can manipulate Brg1 expression in stem cells in culture, we now have a powerful way to generate neurons that could be used to replace cells lost in a variety of diseases and conditions that affect the brain and spinal cord. That is our next step." said Sherman. "Since the process only involves a single gene, it is highly amenable for the development of drugs targeted at promoting stem cell differentiation in the adult nervous system." While much more research needs to be conducted, the scientists believe these findings could play a role in the development of therapies to combat a variety of diseases and conditions. For instance, Parkinson's disease is related to the loss of dopamine-producing brain cells. Scientists hypothesize that it may be possible to correctly time the expression of brg-1 in neuronal stem cells either in a culture dish or in the brain to replace the lost dopamine-producing cells. Another possibility would be the replacement of lost or damaged motor neurons in patients who have suffered brain or spinal cord damage. This research was funded in part by the Medical Research Foundation of Oregon, the National Institute's of Health and the Christopher Reeve Paralysis Foundation. "CRF is pleased to have provided support for this study", said Susan Howley, Director of Research and Executive Vice President, Christopher Reeve Foundation. "Identifying a gene that controls how stem cells turn into different kinds of nerve cells has important implications for clinical application in spinal cord repair strategies." Oregon Health & Science University | |||||||||||||||||||||
|
Related Brain Cells News Articles New methods identify and manipulate 'newborn' cells in animal model of Parkinson's disease When cells in the brain are lost through disease or injury, neighboring cells begin to divide and multiply, but only a few areas in the brain are able to produce new neurons. Gene is likely cause of stroke-inducing vascular malformations UCSF scientists have discovered that a gene controlling whether blood vessels differentiate into arteries or veins during embryonic development is linked to a vascular disorder in the brain that causes stroke. PET scans help identify mechanism underlying seasonal mood changes Brain scans taken at different times of year suggest that the actions of the serotonin transporter-involved in regulating the mood-altering neurotransmitter serotonin-vary by season, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Rapid changes in key Alzheimer's protein described in humans For the first time, researchers have described hour-by-hour changes in the amount of amyloid beta, a protein that is believed to play a key role in Alzheimer's disease, in the human brain. New hope for stroke patients If a stroke patient doesn't get treatment within approximately the first three hours of symptoms, there's not much doctors can do to limit damage to the brain. Largest study of its kind implicates gene abnormalities in bipolar disorder The largest genetic analysis of its kind to date for bipolar disorder has implicated machinery involved in the balance of sodium and calcium in brain cells. Childhood brain tumor traced to normal stem cells gone bad An aggressive childhood brain tumor known as medulloblastoma originates in normal brain "stem" cells that turn malignant when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF). Distinguishing between 2 birds of a feather The bird enthusiast who chronicled the adventures of a flock of red-headed conures in his book "The Wild Parrots of Telegraph Hill" knows most of the parrots by name, yet most of us would be hard pressed to tell one bird from another. Alzheimer's disease patients show improvement in trial of new drug A new drug has been shown to improve the brain function of people with early stage Alzheimer's disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published today in the journal Lancet Neurology and presented at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease. N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction. More Brain Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||